|
HY-W004868-1g
|
MedChemexpress LLC
|
1-Cbz-azetidine-3-carboxylic acid [CAS 97628-92-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W004868-5g
|
MedChemexpress LLC
|
1-Cbz-azetidine-3-carboxylic acid [CAS 97628-92-7]
|
|
Cancer-programmed cell death
|
|
|
HY-W043748-1g
|
MedChemexpress LLC
|
2,5-Dioxopyrrolidin-1-yl acrylate [CAS 38862-24-7]
|
|
|
|
|
HY-W043748-250mg
|
MedChemexpress LLC
|
2,5-Dioxopyrrolidin-1-yl acrylate [CAS 38862-24-7]
|
|
|
|
|
HY-133408-10mg
|
MedChemexpress LLC
|
4-Methyl-4-(methyldisulfanyl)pentanoic acid [CAS 796073-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-133408-100mg
|
MedChemexpress LLC
|
4-Methyl-4-(methyldisulfanyl)pentanoic acid [CAS 796073-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-133408-25mg
|
MedChemexpress LLC
|
4-Methyl-4-(methyldisulfanyl)pentanoic acid [CAS 796073-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-133408-5mg
|
MedChemexpress LLC
|
4-Methyl-4-(methyldisulfanyl)pentanoic acid [CAS 796073-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-133408-50mg
|
MedChemexpress LLC
|
4-Methyl-4-(methyldisulfanyl)pentanoic acid [CAS 796073-55-7]
|
|
Cancer-programmed cell death
|
|
|
HY-15938-10mg
|
MedChemexpress LLC
|
5-FAM SE [CAS 92557-80-7]
|
|
|
|
|
HY-15938-100mg
|
MedChemexpress LLC
|
5-FAM SE [CAS 92557-80-7]
|
|
|
|
|
HY-15938-5mg
|
MedChemexpress LLC
|
5-FAM SE [CAS 92557-80-7]
|
|
|
|
|
HY-15938-50mg
|
MedChemexpress LLC
|
5-FAM SE [CAS 92557-80-7]
|
|
|
|
|
HY-138387-100mg
|
MedChemexpress LLC
|
6-Azido-hexylamine [CAS 349553-73-7]
|
|
Cancer-programmed cell death
|
|
|
HY-138387-250mg
|
MedChemexpress LLC
|
6-Azido-hexylamine [CAS 349553-73-7]
|
|
Cancer-programmed cell death
|
|
|
HY-138387-50mg
|
MedChemexpress LLC
|
6-Azido-hexylamine [CAS 349553-73-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132160A-1mg
|
MedChemexpress LLC
|
7-Aminomethyl-10-methyl-11-fluoro camptothecin (TFA)
|
|
|
|
|
HY-132160A-10mg
|
MedChemexpress LLC
|
7-Aminomethyl-10-methyl-11-fluoro camptothecin (TFA)
|
|
|
|
|
HY-132160A-5mg
|
MedChemexpress LLC
|
7-Aminomethyl-10-methyl-11-fluoro camptothecin (TFA)
|
|
|
|
|
HY-132160-1mg
|
MedChemexpress LLC
|
7-Aminomethyl-10-methyl-11-fluoro camptothecin [CAS 2378616-23-8]
|
|
Cancer-programmed cell death
|
|
|
HY-132160-10mg
|
MedChemexpress LLC
|
7-Aminomethyl-10-methyl-11-fluoro camptothecin [CAS 2378616-23-8]
|
|
Cancer-programmed cell death
|
|
|
HY-132160-5mg
|
MedChemexpress LLC
|
7-Aminomethyl-10-methyl-11-fluoro camptothecin [CAS 2378616-23-8]
|
|
Cancer-programmed cell death
|
|
|
HY-141147-25mg
|
MedChemexpress LLC
|
7-O-(Amino-PEG4)-paclitaxel
|
|
Cancer-programmed cell death
|
|
|
HY-P99242-1mg
|
MedChemexpress LLC
|
Alsevalimab [CAS 2254029-91-7]
|
|
Cancer-programmed cell death
|
|
|
HY-P99242-10mg
|
MedChemexpress LLC
|
Alsevalimab [CAS 2254029-91-7]
|
|
Cancer-programmed cell death
|
|
